Curis Inc reports results for the quarter ended June 30 - Earnings Summary

Curis

14/08/2026 21:59

Curis Inc CRIS.OQ reported a quarterly adjusted loss of $4.02​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-13.60.  The mean expectation of four analysts for the quarter was for a loss of $7.84 per share. Wall Street expected results to range from $-12.20 to $-5.52 per share.
Reported revenue was zero​; analysts expected $1.00 million. 
Curis Inc's reported EPS for the quarter was a loss of $4.02​.
The company reported a quarterly loss of $8.58 million.
Curis Inc shares had fallen by 82.1% this quarter and lost 90.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 12.9% in the last three months.​ 
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Curis Inc is $65.00, about 97.1% above its last closing price of $1.87
This summary was machine generated from LSEG data August 14 at 08:59 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-7.84
-4.02
Beat
Mar. 31 2026 
-8.00
-25.00
Missed
Dec. 31 2025 
-9.00
-10.00
Missed
Sep. 30 2025 
-11.56
-9.80
Beat